5F-MPMI is a tryptamine derivative which acts as a serotonin receptor agonist, selective for the 5-HT2 subtypes but with similar affinity to all three receptors, having strongest activity at 5-HT2B and weakest at 5-HT2A.[1]

See also

References

  1. ^ WO 2022/256554, Wallach J, Dybek M, "Fluorinated Tryptamine Compounds, Analogues Thereof, and Methods Using Same", published 8 December 2022, assigned to University of the Sciences in Philadelphia. 


No tags for this post.